EUVIMEDOpdag EUVIMED
Crossref

Impact of Immunoglobulin M-enriched Immunoglobulins on the Outcomes of Severe Coronavirus Disease 2019

Amit Goyal, Omender Singh, Deven Juneja

Journal of The Association of Physicians of India · 2024

DOI: 10.59556/japi.72.0613 ↗

At a glance

Journal article in Journal of The Association of Physicians of India, 2024. Written by Amit Goyal and 2 co-authors. Institution: Senior Consultant, Institute of Critical Care Medicine, Max Super Speciality Hospital, Delhi, India, Corresponding Author. Major MEDLINE topics: COVID-19, Immunoglobulin M. 28 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

BACKGROUND AND AIM: Coronavirus disease 2019 (COVID-19) led to a major global health crisis, leading to a worldwide pandemic. Several therapeutic interventions have been tried with varied results. The purpose of this academic work was to assess the efficacy of immunoglobulin M (IgM)-enriched Ig in the management of patients with severe COVID-19 pneumonia. MATERIALS AND METHODS: In this retrospective cohort study, severe COVID-19 pneumonia patients who received IgM-enriched immunoglobulin, in addition to standard-of-care treatment, were retrospectively enrolled. Levels of inflammatory biomarkers, oxygenation status, and organ dysfunction were evaluated, and differences were noted after giving IgM-supplemented IgM. RESULTS: Data from 32 consecutive severe COVID-19 patients admitted to medical intensive care units (ICUs) were analyzed. After giving IgM-enriched Ig, there was an improvement in oxygenation indices as shown by saturation of oxygen/fraction of inspired oxygen (SpO2/FiO2) on days 3 and 7, but it was not statistically significant. Oxygen support could be de-escalated in 13 (40.6%) patients on day 3 and in 8 (25%) patients on day 7, after giving IgM-enriched Ig. After giving IgM-enriched Ig, there was a reduction in the levels of all the studied inflammatory markers [interleukin-6 (IL-6), D-dimer, and ferritin) on days 3 and 7, but it was statistically significant only for IL-6. The overall ICU mortality was 53.1%. CONCLUSION: Outcomes of patients with severe COVID-19 requiring ICU care remain dismal. IgM-enriched Ig may be helpful in improving oxygenation and combating cytokine storm in these patients. However, in the present study, the improvement in oxygenation indices (SpO2/FiO2) and reduction in inflammatory markers like D-dimer and ferritin were not statistically significant. Hence, larger randomized controlled trials are required to get more definitive evidence to support this therapy and show significant clinical and mortality benefits.

Subjects

MeSH terms (MEDLINE)

COVID-19Immunoglobulin MHumansRetrospective StudiesMaleMiddle AgedFemaleTreatment OutcomeAdultAgedSARS-CoV-2Fibrin Fibrinogen Degradation ProductsIntensive Care UnitsFerritinsInterleukin-6

Substances

Immunoglobulin Mfibrin fragment DFibrin Fibrinogen Degradation ProductsFerritinsInterleukin-6

Authors and institutions

  • Senior Consultant, Institute of Critical Care Medicine, Max Super Speciality Hospital, Delhi, India, Corresponding Author.
  • Principal Director, Institute of Critical Care Medicine, Max Super Speciality Hospital, Delhi, India.
  • Director, Institute of Critical Care Medicine, Max Super Speciality Hospital, Delhi, India.

Cite

APA

Goyal, A., Singh, O., & Juneja, D. (2024). Impact of Immunoglobulin M-enriched Immunoglobulins on the Outcomes of Severe Coronavirus Disease 2019. Journal of The Association of Physicians of India. https://doi.org/10.59556/japi.72.0613

Vancouver

Goyal A, Singh O, Juneja D. Impact of Immunoglobulin M-enriched Immunoglobulins on the Outcomes of Severe Coronavirus Disease 2019. Journal of The Association of Physicians of India. 2024. doi:10.59556/japi.72.0613

BibTeX
@article{Goyal2024,
  author = {Goyal, Amit and Singh, Omender and Juneja, Deven},
  title = {Impact of Immunoglobulin M-enriched Immunoglobulins on the Outcomes of Severe Coronavirus Disease 2019},
  journal = {Journal of The Association of Physicians of India},
  year = {2024},
  doi = {10.59556/japi.72.0613}
}
Start for free →